Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 37, 2023 - Issue 3
255
Views
2
CrossRef citations to date
0
Altmetric
Research Articles

Separation of a new triterpenoid saponin together with six known ones from Clematis tangutica (Maxim.) Korsh and evaluation of their cytotoxic activities

, , , , , , , , & show all
Pages 375-382 | Received 09 Jul 2021, Accepted 15 Sep 2021, Published online: 29 Sep 2021
 

Abstract

A new triterpenoid saponin, 3-O-β-D-allopyranosyl (1→3)-α-L-rhamnopyranosyl (1→2)-α-L-arabinopyranosyl hederagenin 28-O-α-L-rhamnopyranosyl (1→4)-β-D-glucopyranosyl (1→6)-β-D-glucopyranosyl ester (IV), together with six known ones Hederacholichiside F (I), Tanguticoside B (II), Tauroside St-H1 (III), Hederoside H1 (V), Kalopanaxsaponin G (VI), Hederasaponin B (VII) were separated from Clematis tangutica (Maxim.) Korsh. Their cytotoxic activities were evaluated. Saponins IV (new compound) and I showed selective inhibitory activities against HGC-27 with IC50 values of 20.17 and 66.18 μM. Saponin VII exhibited extensive inhibitory action against HGC-27, Hela and SK-OV-3 with IC50 values of 16.47-71.36 μM. Saponin III showed selective inhibitory activity against SK-OV-3 with the IC50 value of 48.70 μM. All isolated saponins were inactive (IC50 >150 μM) to GES-1.

Graphical Abstract

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This work was supported by the Innovation Platform Construction Project of Qinghai Province [2020-ZJ-T02]; Key Research, Development and Transformation Project of Qinghai Province [2019-SF-123]; Innovation Capability Improvement Project for Colleges and Universities of Gansu Province [2019A-102]; Surface Project of Key Laboratory of Hexi Corridor Resources Utilization of Gansu [XZ1805]; and Joint Research Project of Three-River Headwaters National Park, Chinese Academy of Sciences and The People’s Government of Qinghai Province [LHZX-2020-09].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.